1. Academic Validation
  2. circCYP24A1 facilitates esophageal squamous cell carcinoma progression through binding PKM2 to regulate NF-κB-induced CCL5 secretion

circCYP24A1 facilitates esophageal squamous cell carcinoma progression through binding PKM2 to regulate NF-κB-induced CCL5 secretion

  • Mol Cancer. 2022 Dec 13;21(1):217. doi: 10.1186/s12943-022-01686-7.
Lina Gu # 1 Yang Sang # 2 Xixi Nan 1 Yang Zheng 3 Fei Liu 1 Lingjiao Meng 3 Meixiang Sang 4 5 Baoen Shan 6 7
Affiliations

Affiliations

  • 1 Research Center, the Fourth Hospital of Hebei Medical University, 050017, Shijiazhuang, Hebei, People's Republic of China.
  • 2 Animal Center, the Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, People's Republic of China.
  • 3 Tumor Research Institute, the Fourth Hospital of Hebei Medical University, 050017, Shijiazhuang, Hebei, People's Republic of China.
  • 4 Research Center, the Fourth Hospital of Hebei Medical University, 050017, Shijiazhuang, Hebei, People's Republic of China. [email protected].
  • 5 Tumor Research Institute, the Fourth Hospital of Hebei Medical University, 050017, Shijiazhuang, Hebei, People's Republic of China. [email protected].
  • 6 Research Center, the Fourth Hospital of Hebei Medical University, 050017, Shijiazhuang, Hebei, People's Republic of China. [email protected].
  • 7 Tumor Research Institute, the Fourth Hospital of Hebei Medical University, 050017, Shijiazhuang, Hebei, People's Republic of China. [email protected].
  • # Contributed equally.
Abstract

Background: Esophageal squamous cell carcinoma (ESCC) is a common gastrointestinal malignant tumor, while the molecular mechanisms have not been fully elucidated. Multiple circular RNAs have been reported to involve in the onset and progression of malignant tumors through various molecular mechanisms. However, the clinical significance and functional mechanism of most circRNAs involved in the progression of ESCC remains obscure.

Methods: RNA-Seq was used to explore potential circRNAs in participated in 5 pairs of ESCC and their corresponding normal esophageal tissues. The up-regulated circCYP24A1 was selected. Fluorescence in situ hybridization was cunducted to verificated the expression and intracellular localization of circCYP24A1 by using the tissue microarray. The Kaplan-Meier method and COX proportional hazards model was used to examine the potential prognostic value of circCYP24A1 on overall survival of ESCC patients. The biological function were confirmed by gain- and loss-of-function approaches in vivo. mRNA expression profile microarray was proformed to investigate the downstream signaling pathways involved in circCYP24A1. RNA pull-down assay and mass spectrometry were performed to identify the proteins associated with circCYP24A1. Rescue experiments were carried out to identified hypothetical regulatory role of circCYP24A1 on ESCC progression in vivo and in virto.

Results: In this study, we identified circCYP24A1 in ESCC tissues by RNA sequencing, which is up-regulated in 114 cases of ESCC tissues and acts as a novel prognosis-related factor. Moreover, circCYP24A1 promoted the ability of proliferation, migration, invasion and clone formation in vitro, as well as tumor growth in vivo. Mechanistically, chemokine (C-Cmotif) ligand 5 (CCL5) is functional downstream mediator for circCYP24A1, which is screened by mRNA microarray. Moreover, circCYP24A1 physically interacts with M2 isoform of Pyruvate Kinase (PKM2). Rescue experiments showed that PKM2 knockdown partly reverses the promotional effects of circCYP24A1. It was revealed that circCYP24A1 increases secretion of CCL5 through the mechanism mainly by interacting with PKM2, an activator of NF-κB pathway, and thereby accelerate malignant progression of ESCC.

Conclusions: Up-regulated circCYP24A1 could activate NF-κB pathway by binding PKM2, which promotes the secretion of CCL5 and accelerate malignant progression of ESCC. Our fndings recommended a novel function for circCYP24A1 as a potential effective biomarker for judging prognosis and a therapeutic target in ESCC.

Keywords

CCL5; Esophageal squamous cell carcinoma; NF-κB; PKM2; circCYP24A1.

Figures
Products